834 related articles for article (PubMed ID: 8894183)
1. In vivo microdialysis study of a specific inhibitor of soluble guanylyl cyclase on the glutamate receptor/nitric oxide/cyclic GMP pathway.
Fedele E; Jin Y; Varnier G; Raiteri M
Br J Pharmacol; 1996 Oct; 119(3):590-4. PubMed ID: 8894183
[TBL] [Abstract][Full Text] [Related]
2. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one.
Garthwaite J; Southam E; Boulton CL; Nielsen EB; Schmidt K; Mayer B
Mol Pharmacol; 1995 Aug; 48(2):184-8. PubMed ID: 7544433
[TBL] [Abstract][Full Text] [Related]
3. Release of arginine, glutamate and glutamine in the hippocampus of freely moving rats: Involvement of nitric oxide.
Watts J; Fowler L; Whitton PS; Pearce B
Brain Res Bull; 2005 May; 65(6):521-8. PubMed ID: 15862924
[TBL] [Abstract][Full Text] [Related]
4. Failure of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) to inhibit soluble guanylyl cyclase in rat ventricular cardiomyocytes.
Wegener JW; Closs EI; Förstermann U; Nawrath H
Br J Pharmacol; 1999 Jun; 127(3):693-700. PubMed ID: 10401560
[TBL] [Abstract][Full Text] [Related]
5. Age-related changes in the NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis.
Vallebuona F; Raiteri M
Eur J Neurosci; 1995 Apr; 7(4):694-701. PubMed ID: 7542528
[TBL] [Abstract][Full Text] [Related]
6. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
7. Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release.
Fedele E; Varnier G; Ansaldo MA; Raiteri M
Br J Pharmacol; 1998 Nov; 125(5):1042-8. PubMed ID: 9846643
[TBL] [Abstract][Full Text] [Related]
8. Galanin stimulates the N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in vivo in the rat ventral hippocampus.
Consolo S; Uboldi MC; Caltavuturo C; Bartfai T
Neuroscience; 1998 Aug; 85(3):819-26. PubMed ID: 9639275
[TBL] [Abstract][Full Text] [Related]
9. Desensitization of AMPA receptors and AMPA-NMDA receptor interaction: an in vivo cyclic GMP microdialysis study in rat cerebellum.
Fedele E; Raiteri M
Br J Pharmacol; 1996 Mar; 117(6):1133-8. PubMed ID: 8882607
[TBL] [Abstract][Full Text] [Related]
10. The glutamate receptor/NO/cyclic GMP pathway in the hippocampus of freely moving rats: modulation by cyclothiazide, interaction with GABA and the behavioural consequences.
Fedele E; Conti A; Raiteri M
Neuropharmacology; 1997 Oct; 36(10):1393-403. PubMed ID: 9423927
[TBL] [Abstract][Full Text] [Related]
11. The nitric oxide-cyclic GMP pathway and synaptic plasticity in the rat superior cervical ganglion.
Southam E; Charles SL; Garthwaite J
Br J Pharmacol; 1996 Oct; 119(3):527-32. PubMed ID: 8894173
[TBL] [Abstract][Full Text] [Related]
12. The soluble guanylyl cyclase inhibitor ODQ, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, dose-dependently reduces the threshold for isoflurane anesthesia in rats.
Cechova S; Pajewski TN
Anesth Analg; 2004 Sep; 99(3):752-757. PubMed ID: 15333406
[TBL] [Abstract][Full Text] [Related]
13. Regulatory role of nitric oxide over extracellular taurine in the hippocampus of freely moving rats.
Watts J; Segieth J; Pearce B; Whitton PS
Neurosci Lett; 2004 Mar; 357(3):179-82. PubMed ID: 15003279
[TBL] [Abstract][Full Text] [Related]
14. In vivo microdialysis study of GABA(A) and GABA(B) receptors modulating the glutamate receptor/NO/cyclic GMP pathway in the rat hippocampus.
Fedele E; Varnier G; Raiteri M
Neuropharmacology; 1997 Oct; 36(10):1405-15. PubMed ID: 9423928
[TBL] [Abstract][Full Text] [Related]
15. Low nanomolar serotonin inhibits the glutamate receptor/nitric oxide/cyclic GMP pathway in slices from adult rat cerebellum.
Maura G; Guadagnin A; Raiteri M
Neuroscience; 1995 Sep; 68(2):455-63. PubMed ID: 7477956
[TBL] [Abstract][Full Text] [Related]
16. The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation.
Feelisch M; Kotsonis P; Siebe J; Clement B; Schmidt HH
Mol Pharmacol; 1999 Aug; 56(2):243-53. PubMed ID: 10419542
[TBL] [Abstract][Full Text] [Related]
17. Intrastriatal infusion of (+/-)-S-nitroso-N-acetylpenicillamine releases vesicular dopamine via an ionotropic glutamate receptor-mediated mechanism: an in vivo microdialysis study in chloral hydrate-anesthetized rats.
West AR; Galloway MP
J Neurochem; 1996 May; 66(5):1971-80. PubMed ID: 8780025
[TBL] [Abstract][Full Text] [Related]
18. Altered content and modulation of soluble guanylate cyclase in the cerebellum of rats with portacaval anastomosis.
Monfort P; Corbalán R; Martinez L; López-Talavera J; Córdoba J; Felipo V
Neuroscience; 2001; 104(4):1119-25. PubMed ID: 11457595
[TBL] [Abstract][Full Text] [Related]
19. The nitric oxide donors, SNAP and DEA/NO, exert a negative inotropic effect in rat cardiomyocytes which is independent of cyclic GMP elevation.
Sandirasegarane L; Diamond J
J Mol Cell Cardiol; 1999 Apr; 31(4):799-808. PubMed ID: 10329207
[TBL] [Abstract][Full Text] [Related]
20. Modulation of relaxation to levcromakalim by S-nitroso-N-acetylpenicillamine (SNAP) and 8-bromo cyclic GMP in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1998 Jul; 124(6):1219-26. PubMed ID: 9720794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
